Testing effectiveness (Phase 2)Ended earlyNCT02525692
What this trial is testing
Oral ONC201 in Adult Recurrent Glioblastoma
Who this might be right for
GlioblastomaDiffuse Midline GliomaH3 K27M Glioma+3 more
Jazz Pharmaceuticals 84
Showing 12 of 12 results